RetinalGenix Technologies Inc. 8-K

What Happened
RetinalGenix Technologies Inc. announced in an 8‑K that Liebman Hymowitz, LLP (LH) resigned as the company’s independent registered public accounting firm effective July 13, 2026. LH’s audit reports for the years ended December 31, 2025 and 2024 were not adverse or qualified, but included an explanatory paragraph expressing substantial doubt about the Company’s ability to continue as a going concern. On July 15, 2026, RetinalGenix engaged Vilki & Co., Chartered Accountants, as its new independent registered public accounting firm for the year ending December 31, 2026, effective immediately.

Key Details

• Resignation date: Liebman Hymowitz resigned effective July 13, 2026.
• New auditor: Vilki & Co. engaged effective July 15, 2026 for fiscal 2026.
• Audit opinions: LH’s reports for 2025 and 2024 contained no adverse opinion or disclaimer and were not qualified, but included a going‑concern explanatory paragraph.
• Disagreements/reportable events: The company reported no disagreements with LH and no reportable events for 2024, 2025, or the interim period through July 13, 2026, except previously disclosed control matters; the company also reported no consultations, disagreements, or reportable events with Vilki & Co. for the periods reviewed.
• Follow up filing: RetinalGenix requested LH provide a letter to the SEC about these statements; that letter will be filed as Exhibit 16.1 when received.

Why It Matters
A change in independent auditor is material because auditors review and attest to the company’s financial statements. The LH audit included a going‑concern explanatory paragraph, which signals prior auditor concern about the company’s ability to continue without additional funding or restructuring—an important fact for investors assessing risk. The company reports no auditor disagreements, and it has appointed Vilki & Co. immediately; investors should watch upcoming filings (including the LH letter and future audited or quarterly reports) for further information on the company’s financial condition and any audit findings.